1. Market Research
  2. > Therapy Industry

Cardiovascular Drug Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Pharmaceutical, Packaging, Cardiovascular Disease, Drug Delivery, Generic Drug, Enzyme, Vaccine, Analgesic, Computed Tomography, Diagnostics, Lipid Modifying Drug, Monoclonal Antibody, Point Of Care Testing, Respiratory Treatment.


 
1-10 of 13 reports for Cardiovascular Drug

Purchase Reports From Reputable Market Research Publishers

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

Physician Views: New data for Novartis% LCZ696 set the Street abuzz, but how do cardiologists see it fitting into highly genericised heart failure market?

  • € 685
  • Industry report
  • Dec 2016
  • by Firstword Pharma

The potential blockbuster status of Novartis' LCZ696 has seemingly been cemented in the eyes of the Street thanks to solid results from the Phase III PARADIGM-HF study that were presented over the weekend. ...

Softgel Capsules Market Analysis & Trends - Application(Health supplement, Vitamins & Dietary Supplements, CardiovascularDrugs, Anti-Inflammatory Drugs and Antibiotic & Antibacterial Drugs), End-User

Softgel Capsules Market Analysis & Trends - Application(Health supplement, Vitamins & Dietary Supplements, CardiovascularDrugs, Anti-Inflammatory Drugs and Antibiotic & Antibacterial Drugs), End-User

  • € 3818
  • Industry report
  • November 2016
  • by Accuray Research LLP

The Global Softgel Capsules Market is poised to grow at a CAGR of around 5.4% over the next decade to reach approximately $316.6 billion by 2025. Some of the prominent trends that the market is witnessing ...

Global Halal Pharmaceuticals Market Analysis & Trends - Product Type (Capsules, Tablets, Syrups), Drug Classes (Endocrine Drugs, Respiratory Drugs, Pain Medications, Cardiovascular Drugs), Source Material - Forecast to 2025

Global Halal Pharmaceuticals Market Analysis & Trends - Product Type (Capsules, Tablets, Syrups), Drug Classes (Endocrine Drugs, Respiratory Drugs, Pain Medications, Cardiovascular Drugs), Source Material - Forecast to 2025

  • € 3818
  • Industry report
  • October 2016
  • by Accuray Research LLP

The Global Halal Pharmaceuticals Market is poised to grow at a CAGR of around XX% over the next decade to reach approximately $XX million by 2025. Some of the prominent trends that the market is witnessing ...

Cardiovascular Drugs Companies in China

Cardiovascular Drugs Companies in China

  • € 1636
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Cardiovascular Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing ...

Cardiovascular Drugs Markets in China

Cardiovascular Drugs Markets in China

  • € 3636
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

China's demand for Cardiovascular Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

Cardiovascular Drugs Industry Forecasts - China Focus

Cardiovascular Drugs Industry Forecasts - China Focus

  • € 909
  • Industry report
  • March 2016
  • by Asia Market Information & Development Company

This study focuses on China’s Cardiovascular Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities ...

Branded Generics Market: By Type (Value Added and Trade Named); By Applications: (Cardiovascular Drugs, Anti-Cancer Drugs, CNS Drugs, Anti-Infective Drugs); By Distribution; By Geography & Forecast - (2016 -2021)

Branded Generics Market: By Type (Value Added and Trade Named); By Applications: (Cardiovascular Drugs, Anti-Cancer Drugs, CNS Drugs, Anti-Infective Drugs); By Distribution; By Geography & Forecast - (2016 -2021)

  • € 4773
  • Industry report
  • February 2016
  • by Industry ARC

Branded generics drugs are similar to the innovator products but are marketed and sold under different brand names. The color, size and shape of the brands of the same medicine may vary depending on the ...

The 2016-2021 Outlook for Cardiovascular Drugs in the United States

The 2016-2021 Outlook for Cardiovascular Drugs in the United States

  • € 541
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for cardiovascular drugs across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry earnings ...

The 2016-2021 Outlook for Cardiovascular Drugs in India

The 2016-2021 Outlook for Cardiovascular Drugs in India

  • € 541
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for cardiovascular drugs across the states, union territories and cities of India. Latent demand (in millions of U.S. dollars), or potential industry ...

The 2016-2021 Outlook for Cardiovascular Drugs in Greater China

The 2016-2021 Outlook for Cardiovascular Drugs in Greater China

  • € 541
  • Industry report
  • September 2015
  • by ICON Group

This econometric study covers the latent demand outlook for cardiovascular drugs across the regions of Greater China, including provinces, autonomous regions (Guangxi, Nei Mongol, Ningxia, Xinjiang, Xizang ...

About 1700 reports for Cardiovascular Drug

Download Unlimited Documents from Trusted Public Sources

Cardiovascular Drug Market in the US - Forecast

  • January 2015
    5 pages
  • Cardiovascular ...  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.